Overview
Haritha Mikkilineni is an Internal Medicine provider in Southlake, Texas. Her top areas of expertise are Cannabinoid Hyperemesis Syndrome (CHS), Respiratory Syncytial Virus (RSV) Infection, Folliculitis, and Boils.
Her clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER COMMERCIAL
Locations
420 N Kimball Ave Ste 140, Southlake, TX 76092
2450 S Telshor Blvd, Las Cruces, NM 88011
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
William R. Lumry M.D. P.A.
William Lumry is an Internal Medicine provider in Dallas, Texas. Dr. Lumry is highly rated in 16 conditions, according to our data. His top areas of expertise are Hereditary Angioedema, Angioedema, Hives, and Primary Immunodeficiency (PID).
Texas Oncology, P.A.
Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is highly rated in 13 conditions, according to our data. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, HER2 Negative Breast Cancer, and Tissue Biopsy.
Texas Digestive Disease Consultants
Timothy Ritter is an Internal Medicine specialist and a Gastroenterologist in Southlake, Texas. Dr. Ritter is highly rated in 9 conditions, according to our data. His top areas of expertise are Ulcerative Colitis, Crohn's Disease, Hemorrhagic Proctocolitis, Colonoscopy, and Endoscopy.
Frequently Asked Questions about Dr. Haritha Mikkilineni
How do I make an appointment with Dr. Haritha Mikkilineni?
You can book an appointment with Dr. Haritha Mikkilineni by calling their office at 214-702-5225. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Haritha Mikkilineni a top-rated expert for Cannabinoid Hyperemesis Syndrome (CHS)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Haritha Mikkilineni is classified as an Experienced expert for Cannabinoid Hyperemesis Syndrome (CHS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Haritha Mikkilineni specialize in?
While Dr. Haritha Mikkilineni is a Internal Medicine, they have specific expertise in Cannabinoid Hyperemesis Syndrome (CHS), Respiratory Syncytial Virus (RSV) Infection, and Folliculitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Haritha Mikkilineni participate in research or clinical trials?
Yes. Dr. Haritha Mikkilineni has published 3 articles and abstracts on conditions like Cannabinoid Hyperemesis Syndrome (CHS). You can view a list of Dr. Haritha Mikkilineni's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Haritha Mikkilineni accept my insurance?
Dr. Haritha Mikkilineni accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 214-702-5225 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BoilsDr. Mikkilineni isExperienced. Learn about Boils.
- Cannabinoid Hyperemesis Syndrome (CHS)Dr. Mikkilineni isExperienced. Learn about Cannabinoid Hyperemesis Syndrome (CHS).
- CarbuncleDr. Mikkilineni isExperienced. Learn about Carbuncle.
- FolliculitisDr. Mikkilineni isExperienced. Learn about Folliculitis.
- Respiratory Syncytial Virus (RSV) InfectionDr. Mikkilineni isExperienced. Learn about Respiratory Syncytial Virus (RSV) Infection.